Dear colleagues! after exciting ASH 2021 and EHA 2022 annual congresses and fundamental updates in the field of DLBCL, the idea was born to organize a preceptorship-meeting at University Hospital Würzburg (UKW). German and international colleagues discussed the changed DLBCL landscape and arising implications. Our main scientific objectives were:
Discussion of the updated DLBCL treatment landscape
Exchange of “hands on experience” regarding novel therapies under peers
Increase of awareness of novel treatment-sequencing modalities within the community.
We are happy to let you re-live the meeting via our on-demand videos Best regards,
Johannes Düll, Senior physician Universitätsklinik Würzburg